TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

CUMBERLAND

RespiratoryCardiovascularImmunology
Specialty

CUMBERLAND is a specialty pharmaceutical company focused on Respiratory, Cardiovascular, Immunology.

2005
Since
5
Drugs
-
Trials
2
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

SANCUSO 2024-09-16
Labeling
OMECLAMOX-PAK 2024-05-01
Labeling
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Respiratory 33%
0 drugs Phase 2: 2
Cardiovascular 33%
0 drugs Phase 2: 2
Immunology 17%
0 drugs Phase 2: 1
Dermatology 17%
0 drugs Phase 2: 1

Pipeline Strength Pro

Loading...

Competitors Pro

Novartis big-pharma
Cardiovascular, Immunology, Respiratory
BAUSCH specialty
Dermatology, Immunology, Cardiovascular
AstraZeneca big-pharma
Respiratory, Cardiovascular, Immunology
COREPHARMA other
Cardiovascular, Respiratory, Immunology, Dermatology
COSETTE other
Cardiovascular, Dermatology, Immunology